Scholarlink

Background <p>Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has become a significant concern in plastic surgery, particularly following the 2019 recall of Allergan macro-textured implants. While research has addressed its epidemiology and management, a comprehensive analysis of global publication trends is lacking. This study provides a bibliometric evaluation of the scientific literature on BIA-ALCL, identifying key contributors, research trends, and emerging areas of interest.</p> Methods <p>A bibliometric analysis was conducted using the&#xa0;Web of Science Core Collection&#xa0;to retrieve&#xa0;English-languagepublications on BIA-ALCL from&#xa0;1995 to 2024. Bibliometric indicators, including&#xa0;publication trends, authorship, country contributions, institutional affiliations, and citation impact, were analyzed.&#xa0;VOSviewer 1.6.20&#xa0;was used for keyword co-occurrence and cluster analyses.</p> Results <p>A total of&#xa0;1,148 publications&#xa0;were identified, with a sharp increase after&#xa0;2018. The&#xa0;United States&#xa0;contributed the most research (43.81%), followed by&#xa0;Italy, England, Australia, and Brazil. Cluster analysis revealed four thematic areas:&#xa0;clinical presentation and risk factors, diagnostic strategies, epidemiology and treatment, and etiological hypotheses. The most cited article was&#xa0;Keech et al. (1997), documenting an early case of BIA-ALCL.</p> Conclusions <p>This bibliometric analysis highlights the increasing research focus on&#xa0;implant surface characterization, disease etiology, and patient management. These findings provide valuable insights into the evolution of BIA-ALCL literature and may inform future research and clinical decision-making in plastic surgery.</p> Level of Evidence V <p>This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors &#xa0;<a href="http://www.springer.com/00266">www.springer.com/00266</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): A Bibliometric Analysis of Publication Trends

  • 期刊论文

  • 发表日期：

    2025年3月28日

查看全文
  • Edoardo Caimi,
  • Stefano Vaccari,
  • Valeriano Vinci

摘要

Background

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has become a significant concern in plastic surgery, particularly following the 2019 recall of Allergan macro-textured implants. While research has addressed its epidemiology and management, a comprehensive analysis of global publication trends is lacking. This study provides a bibliometric evaluation of the scientific literature on BIA-ALCL, identifying key contributors, research trends, and emerging areas of interest.

Methods

A bibliometric analysis was conducted using the Web of Science Core Collection to retrieve English-languagepublications on BIA-ALCL from 1995 to 2024. Bibliometric indicators, including publication trends, authorship, country contributions, institutional affiliations, and citation impact, were analyzed. VOSviewer 1.6.20 was used for keyword co-occurrence and cluster analyses.

Results

A total of 1,148 publications were identified, with a sharp increase after 2018. The United States contributed the most research (43.81%), followed by Italy, England, Australia, and Brazil. Cluster analysis revealed four thematic areas: clinical presentation and risk factors, diagnostic strategies, epidemiology and treatment, and etiological hypotheses. The most cited article was Keech et al. (1997), documenting an early case of BIA-ALCL.

Conclusions

This bibliometric analysis highlights the increasing research focus on implant surface characterization, disease etiology, and patient management. These findings provide valuable insights into the evolution of BIA-ALCL literature and may inform future research and clinical decision-making in plastic surgery.

Level of Evidence V

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors  www.springer.com/00266.